TipRanks
Go Ultimate55% OFF

NurExone Biologic (NRX) Income Statement

NurExone Biologic Income Statement

Last quarter (Q2 2026), NurExone Biologic's total revenue was $0.00. In Q2, NurExone Biologic's net income was $-1.68M. See NurExone Biologic’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementMar 26Mar 25Mar 24Dec 22Mar 22
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 6.32M$ 5.01M$ 3.66M$ 7.62M$ 1.68M
Depreciation and Amortization$ 185.00K$ 85.00K$ 33.00K$ 6.00K$ 0.00
$ -6.17M$ -4.94M$ -3.60M$ -8.13M$ -1.68M
$ -6.32M$ -5.01M$ -3.66M$ -7.62M$ -1.68M
$ -61.00K$ -35.00K$ 18.00K$ -550.00K$ 64.89K
$ -6.38M$ -5.04M$ -3.64M$ -8.17M$ -1.62M
$ -6.38M$ -5.04M$ -3.64M$ -8.17M$ -1.62M
Per Share Metrics
Basic EPS$ -0.08$ -0.08$ -0.08$ -0.22$ -0.99
Diluted EPS$ -0.08$ -0.08$ -0.08$ -0.22$ -0.99
Weighted Average Shares Outstanding80.02M65.42M44.72M37.73M1.65M
Weighted Average Shares Outstanding (Diluted)80.02M65.42M44.72M37.73M1.65M

Currency in USD

NurExone Biologic Earnings and Revenue History

-9M-6M-3M00 %0.4 %0.8 %1.2 %EarningsProfit Margin20212022202320242025RevenueEarningsProfit Margin